30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jeffrey Castelli

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice President - Program and Portfolio Management Amicus Therapeutics Inc Feb. 1, 2013 - Jan. 1, 2015
Jeffrey Castelli's trades of Amicus Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-26 2025-11-24
S Sale
84,120 -31.7%
334.69
US$3,624,669 		84,120 -31.7% 334.69 US$3,624,669
2025-11-24 2025-11-24
PrS Proposed sale
40,464
305.80
US$2,471,070 		40,464 305.80 US$2,471,070
2023-12-29 2023-12-28
S Sale
71,088 +1.8%
179.45
US$4,884,700 		71,088 +1.8% 179.45 US$4,884,700
2023-12-28 2023-12-28
PrS Proposed sale
1,575
14.43
US$22,727 		1,575 14.43 US$22,727
2023-12-20 2023-12-20
PrS Proposed sale
17,500
13.18
US$230,650 		17,500 13.18 US$230,650
2023-12-20 2023-12-20
S Sale
1,654 -0.5%
13.10
US$21,667 		1,654 -0.5% 13.10 US$21,667
2023-12-20 2023-12-19
S Sale
17,500 -4.6%
13.25
US$231,875 		17,500 -4.6% 13.25 US$231,875
2023-12-19 2023-12-19
PrS Proposed sale
17,500
12.66
US$221,550 		17,500 12.66 US$221,550